Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Saurabh Jain | Interim CEO & Executive Chairman | 150k | -- | -- |
| Mr. Mark Ziirsen | Chief Financial Officer | 229.43k | -- | 1963 |
| Mr. Damon Rasheed | CTO & Executive Director | 27.78k | -- | -- |
| Mr. Shane Lewis | Vice President of Sales & Partnerships | -- | -- | -- |
| Mr. Scott Sorochak | Chief Revenue Officer | -- | -- | -- |
| Mr. Jonathan Hart B.Com., L.L.B. | Company Secretary | -- | -- | 1983 |
Opyl Limited
- Sector:
- Healthcare
- Industry: Health Information Services
Description
Opyl Limited engages in the development of digital tools that enhance healthcare experience for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs for pharmaceuticals, medical devices, alternative therapies, and novel conditions. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process for biopharma, MedTech, government, and healthcare organizations. The company was formerly known as ShareRoot Limited and changed its name to Opyl Limited in December 2019. Opyl Limited was incorporated in 1994 and is based in Milsons Point, Australia.
Corporate Governance
Upcoming Events
February 26, 2025 at 10:59 AM UTC - March 3, 2025 at 12:00 PM UTC
Opyl Limited Earnings Date
Recent Events
Recent Events Information Not Available